On May 23, 2025 a Boston University School of Public Health (BUSPH) led study revealed that there were…
On May 19, 2025, researchers at the Broad Institute Ben Neale and Mark Daly are co-leading the study,…
On May 15, 2025, researchers at the Translational Genomics Research Institute (TGen), part of City of Hope, announced…
On Apr. 21, 2025, the National Institutes of Health (NIH) reported that overall death rates from cancer declined steadily among…
On Jan. 13, 2025, a study led by NYU Langone Health shows that the risk of developing dementia at…
On Dec. 20, 2024, the U.S. Food and Drug Administration (FDA) approved Eli Lilly’s Zepbound (tirzepatide) for the…
On Dec. 19, 2024, the U.S. Food and Drug Administration announced it had updated the definition of “healthy…
On Nov. 21, 2024, teams at the University of Texas Southwestern Medical Center report a new way that…
On Nov. 14, 2024, an analysis from the Global Burden of Disease Study Collaborator Network warned of an…
On Sep. 13, 2024, a Cleveland Clinic study was announced that identified key factors that can impact the…
On Aug. 13, 2024, Eli Lilly announced the opening of the Lilly Seaport Innovation Center (LSC), a research…
On Jun. 24, 2024, Novo Nordisk announced plans to invest 4.1 billion US dollars to build a second…
On Mar. 8, 2024, the U.S. Food and Drug Administration approved a new indication for use of Novo…
On Nov. 8, 2023, the U.S. Food and Drug Administration approved Eli Lilly’s Zepbound (tirzepatide) injection for chronic…
On Jun. 1, 2022, the U.S. National Institutes of Health announced that an NIH funded study had found…
On Jun. 21, 2021, Cumberland Pharma released a series of case reports describing the effectiveness of Vibativ (telavancin)…
On Jun. 4, 2021, the U.S. Food and Drug Administration announced it had approved Novo Nordisk’s Wegovy (semaglutide)…
On Jun. 4, 2021, the U.S. Food and Drug Administration approved Novo Nordisk’s Wegovy (semaglutide) injection (2.4 mg…
On Dec. 4, 2020, Novo Nordisk announced that the FDA approved an updated label for Saxenda (liraglutide) injection…
On Nov. 4, 2020, scientists at the University of Oxford announced they had discovered that obesity can increase…
On Oct. 13, 2020, the National Institute on Drug Abuse (NIDA) and nine other institutes, all part of…
On Sept. 15, 2020, a team of scientists in the U.S. Department of Agriculture’s (USDA) Agriculture Research Service…
On Sept. 15, 2020, UT Southwestern research suggested conditions related to obesity, including inflammation and leaky gut, leave…
On Jul. 27, 2020, Albert Einstein College of Medicine announced that it had received a $9.5 million, five-year…
On Aug. 24, 2018, the Cancer Prevention and Research Institute of Texas (CPRIT) announced it passed a $2…
On Dec. 23, 2014, Novo Nordisk the FDA approved a formulation of Novo Nordiskﾒs diabetes drug, liraglutide, for…
In 2006, Texas Biomed researchers published a genetic linkage map for the rhesus monkey. In 1999, Texas Biomed…
On Nov. 10, 2005, Stanford researchers announced they had discovered obestatin, a hormone that suppresses appetite. The discovery…
On Oct. 11, 2005, the National Cancer Institute announced the Transdisciplinary Research on Energetics and Cancer (TREC) initiative…
On May 11, 2004, the University of Alabama Medical Center’s opened a new $13.5 million 77,000 square foot…